Evidence map›Paper›PMID 29661991›Full record

Trial reportInternational journal of environmental research and public health2018

Information to Improve Public Perceptions of the Food and Drug Administration (FDA's) Tobacco Regulatory Role.

Amira Osman, Sarah D Kowitt, Paschal Sheeran, Kristen L Jarman, Leah M Ranney, Adam O Goldstein

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. The importance of psychology for shaping legal cannabis regulation.Experimental and clinical psychopharmacology · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amira OsmanLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. amirao@email.unc.edu.
Sarah D KowittDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, USA. kowitt@email.unc.edu.
Paschal SheeranDepartment of Psychology and Neuroscience, University of North Carolina, Chapel Hill, NC 27599, USA. psheeran@email.unc.edu.
Kristen L JarmanLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. jkristen@email.unc.edu.ORCID 0000-0002-6707-3058
Leah M RanneyDepartment of Family Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. Leah_Ranney@unc.edu.ORCID 0000-0001-9766-4767
Adam O GoldsteinLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. adam_goldstein@med.unc.edu.

Funding

Training & Education Program p294-308P50CA180907 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RIBISL, KURT M. · 2013 to 2017
$20.2M
NCI NIH HHS P50 CA180907
6 · The paper itself

Abstract

While the Food and Drug Administration (FDA) has had regulatory authority over tobacco products since 2009, public awareness of this authority remains limited. This research examines several broad types of information about FDA tobacco regulatory mission that may improve the perceptions of FDA as a tobacco regulator. Using Amazon Mechanical Turk, 1766 adults, smokers and non-smokers, were randomly assigned to view a statement about FDA regulatory authority that varied three information types in a 2 × 2 × 2 between subjects experimental design: (1) FDA's roles in regulating tobacco (yes/no); (2) The scientific basis of regulations (yes/no); and (3) A potential protective function of regulations (yes/no). Using factorial ANOVA, we estimated the main and interactive effects of all three types of information and of smoking status on the perceptions of FDA. Participants that were exposed to information on FDA roles reported higher FDA credibility and a greater perceived knowledge of FDA than those who did not. Exposure to information about the scientific basis of regulations led to more negative views of the tobacco industry. Participants who learned of the FDA's commitment to protecting the public reported higher FDA credibility and more positive attitudes toward regulations than those who did not learn of this commitment. We observed no significant interaction effects. The findings suggest that providing information about the regulatory roles and protective characterization of the FDA's tobacco regulatory mission positively influence public perceptions of FDA and tobacco regulations.

Indexed as

Attitude to HealthGovernment RegulationPerceptionAdolescentAdultAgedConsumer Health InformationFemaleHumansMaleMiddle AgedTobacco IndustryTobacco ProductsUnited StatesUnited States Food and Drug AdministrationYoung AdultFDAperceptionssource credibilitytobacco regulations

Identifiers

PMID29661991
PMCPMC5923795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.